These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35386180)

  • 21. Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
    Oladapo A; Kolodny S; Vredenburg M; Swallow E; Goldschmidt D; Sarathy K; Lopez P; Maitland H; Yee J
    Ther Adv Hematol; 2023; 14():20406207231179856. PubMed ID: 37465395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation.
    Fu H; Lv M; Liu H; Sun Y; Zhang Y; Mo X; Han T; Wang F; Yan C; Wang Y; Kong J; Han W; Chen H; Chen Y; Chen Y; Xu L; Liu K; Huang X; Zhang X
    Bone Marrow Transplant; 2023 Dec; 58(12):1368-1376. PubMed ID: 37679646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies.
    Kuter DJ; Allen LF
    Br J Haematol; 2018 Nov; 183(3):466-478. PubMed ID: 30203841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag.
    Van de Vondel S; Vandenbriele C; Gheysens G; Verhamme P; Janssens A
    Res Pract Thromb Haemost; 2023 Mar; 7(3):100125. PubMed ID: 37065845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.
    Abdela J
    Clin Med Insights Blood Disord; 2019; 12():1179545X19875105. PubMed ID: 31673229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension.
    Al-Samkari H; Nagalla S
    Platelets; 2022 Feb; 33(2):257-264. PubMed ID: 33586606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li C; Li X; Huang F; Yang J; Wu A; Wang L; Qin D; Zou W; Wu J
    Front Pharmacol; 2019; 10():829. PubMed ID: 31402863
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S; Terrault NA
    Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease.
    Al-Samkari H
    Drugs Today (Barc); 2018 Nov; 54(11):647-655. PubMed ID: 30539164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia.
    Kuter DJ; Tarantino MD; Lawrence T
    Blood Rev; 2021 Sep; 49():100811. PubMed ID: 33781612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Terrault N; Chen YC; Izumi N; Kayali Z; Mitrut P; Tak WY; Allen LF; Hassanein T
    Gastroenterology; 2018 Sep; 155(3):705-718. PubMed ID: 29778606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis.
    Hu R; Guo S; Liu M
    Heliyon; 2024 Jan; 10(1):e24051. PubMed ID: 38268581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study.
    Wang YS; Wang W; Zhang S; Zhang SY; Shen AZ; Wang W; Song HC; Yao HZ; Song RP; Meng FZ; Li L; Nashan B; Wang JZ; Liu LX
    Front Pharmacol; 2022; 13():1009612. PubMed ID: 36267268
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative Efficacy and Safety of Thrombopoietin Receptor Agonists in Adults With Thrombocytopenia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trial.
    Deng J; Hu H; Huang F; Huang C; Huang Q; Wang L; Wu A; Yang J; Qin D; Zou W; Wu J
    Front Pharmacol; 2021; 12():704093. PubMed ID: 34393785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials.
    Shen N; Qiao J; Jiang Y; Yin H; Li M; Zhu S; Li J
    Exp Ther Med; 2023 Aug; 26(2):393. PubMed ID: 37456173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avatrombopag for the salvage treatment of platelet transfusion refractoriness.
    Qin Y; Wang Y; Zhang Y; Jiao Y; Ye J
    Ther Adv Hematol; 2024; 15():20406207241237606. PubMed ID: 38481948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Romiplostim as a treatment for immune thrombocytopenia: a review.
    Chalmers S; Tarantino MD
    J Blood Med; 2015; 6():37-44. PubMed ID: 25632241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia.
    Eguchi Y; Takahashi H; Mappa S; Santagostino E
    Hepatol Res; 2022 Apr; 52(4):371-380. PubMed ID: 35134259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.
    Bussel JB; Kuter DJ; Aledort LM; Kessler CM; Cuker A; Pendergrass KB; Tang S; McIntosh J
    Blood; 2014 Jun; 123(25):3887-94. PubMed ID: 24802775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.